Left ventricular heart failure and pulmonary hypertension

European Heart Journal

Volumn 37, Issue 12, 2016, Pages 942-954

  Rosenkranz, Stephan ^a   Gibbs, J Simon R ^b,c   Wachter, Rolf ^d,e   De Marco, Teresa ^f   Vonk Noordegraaf, Anton ^g   Vachiéry, Jean Luc ^h  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ERASME HOSPITAL   (Belgium)

Author keywords

Heart failure; Post capillary; Pre capillary; Pulmonary hypertension

Indexed keywords

NATRIURETIC FACTOR;

ARTERY COMPLIANCE; BLOOD PRESSURE; BLOOD VESSEL COMPLIANCE; CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; DIASTOLIC PRESSURE GRADIENT; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FIBROSING ALVEOLITIS; FORWARD HEART FAILURE; FUNCTIONAL DISEASE; HEART ATRIOVENTRICULAR VALVE; HEART CATHETERIZATION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT ATRIUM PRESSURE; HEART TRANSPLANTATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; LEFT VENTRICULAR ASSIST DEVICE; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG EDEMA; LUNG HEMODYNAMICS; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MITRAL VALVE REGURGITATION; NON INVASIVE PROCEDURE; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PRESSURE GRADIENT; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERIAL WEDGE PRESSURE; PULMONARY ARTERY SYSTOLIC PRESSURE; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REVIEW; STANDARDIZATION; SYSTOLIC BLOOD PRESSURE; TRANSPULMONARY PRESSURE GRADIENT; TRICUSPID VALVE REGURGITATION; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HYPERTENSION, PULMONARY; MITRAL VALVE INSUFFICIENCY; PHYSIOLOGY;

HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MITRAL VALVE INSUFFICIENCY; PHENOTYPE; PULMONARY CIRCULATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84964658601     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv512     Document Type: Review

References (70)

1. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537
2. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34-D41
3. Rosenkranz S. Pulmonary hypertension 2015: Current definitions, terminology, and novel treatment options. Clin Res Cardiol 2015; 104: 197-207
4. Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62(Suppl D): D60-D72
5. Lüscher TF. Pulmonary embolism and pulmonary hypertension: Two issues often neglected in cardiology. Eur Heart J 2015; 36: 581-583
6. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D42-D50
7. Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, Gomberg-Maitland M, Murali S, Frantz RP, McGlothlin D, Horn EM, Benza R. World Health Organization pulmonary hypertension group 2: Pulmonary hypertension due to left heart disease in the adult - A summary statement from the pulmonary hypertension council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2012; 31: 913-933
8. Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction. JACC Heart Fail 2013; 1: 290-299
9. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013; 41: 217-223
10. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM. Diastolic pulmonary vascular pressure gradient. A predictor of prognosis in out-ofproportion pulmonary hypertension. Chest 2013; 143: 758-766
11. Vachiery J.L. Adir Y, Barbera JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs JS, Martinez F, Semigran M, Simonneau G, Wells A, Seeger W. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013; 62(Suppl D): D100-D108
12. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2015; doi: 10.1093/eurheartj/ehv317
13. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001; 37: 183-188
14. Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ. The diagnostic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 2015; 3: 9-16
15. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction. A community-based study. J Am Coll Cardiol 2009; 53: 1119-1126
16. Leung CC, Moondra V, Catherwood E, Andrus BW. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol 2010; 106: 284-286
17. Shah AM, Shah SJ, Annand IS, Sweitzer NK, O'Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD; TOPCAT Investigators. Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial (TOPCAT). Circ Heart Fail 2014; 7: 104-115
18. Bursi F, McNallan SM, Redfield MM, Nkomo VT, Lam CS, Weston SA, Jiang R, Roger VL. Pulmonary pressures and death in heart failure. J Am Coll Cardiol 2012; 59: 222-231
19. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014; 35: 3452-3462
20. Mohammed SF, Hussain I, Abou Ezzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL, Redfield MM. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 2014; 130: 2310-2320
21. Pellegrini P, Rossi A, Pasotti M, Raineri C, Cicoira M, Bonapace S, Dini FL, Temporelli PL, Vassanelli C, Vanderpool R, Naeije R, Ghio S. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest 2014; 145: 1064-1070
22. Dragu R, Rispler S, Habib M, Sholy H, Hammerman H, Galie N, Aroson D. Pulmonary arterial capacitance in patients with with heart failure and reactive pulmonary hypertension. Eur J Heart Fail 2015; 17: 74-80
23. Al-Naamani N, Preston IR, Paulus JK, Hill NS, Roberts KE. Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction. JACC Heart Fail 2015; 3: 467-474
24. Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, Hassoun PM, Leary PJ, Kass DA, Shah AS. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant 2014; 33: 289-297
25. Rossi A, Gheorghiade M, Triposkiadis F, Solomon SD, Pieske B, Butler J. Left atrium in heart failure with preserved ejection fraction: Structure, function, and significance. Circ Heart Fail 2014; 7: 1042-1049
26. Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail 2015; 8: 295-303
27. Sanchis L, Gabrielli L, Andrea R, Falces C, Duchateau N, Perez-Villa F, Bijnens B, Sitges M. Left atrial dysfunction relates to symptom onset in patients with heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging 2015; 16: 62-67
28. Ten Freyhaus H, Dagnell M, Leuchs M, Vantler M, Berghausen E, Caglayan E, Weissmann N, Dahal BK, Schermuly RT, Östman A, Kappert K, Rosenkranz S. Hypoxia enhances PDGF signaling in the pulmonary vasculature by downregulation of protein tyrosine phosphatases. Am J Respir Crit Care Med 2011; 183: 1092-1102
29. Chen Y, Guo H, Xu D, Xu X, Wang H, Hu X, Lu Z, Kwak D, Xu Y, Gunther R, Huo Y, Weir EK. Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: Heart failure causes severe lung disease. Hypertension 2012; 59: 1170-1178
30. Delgado JF. The right heart and pulmonary circulation (III): The pulmonary circulation in heart failure. Rev Esp Cardiol 2010; 63: 334-345
31. Kutty RS, Parameshwar J, Lewis C, Catarino PA, Sudarshan CD, Jenkins DP, Dunning JJ, Tsui SS. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiovasc Surg 2013; 43: 1237-1242
32. Lundgren J, Algotsson L, Kornhall B, Radegran B. Preoperative pulmonary hypertension and its impact on survival after heart transplantation. Scand Cardiovasc J 2014; 48: 47-58
33. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, Cingolani OH, Mudd JO, Borlaug BA, Redfield MM, Lederer DJ, Kass DA. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012; 125: 289-297
34. Van Empel VP, Kaufmann BA, Bernheim AM, Goetschalckx K, Min SY, Muzzarelli S, Pfisterer ME, Kiencke S, Maeder MT, Brunner-La Rocca H-P. Interaction between pulmonary hypertension and diastolic dysfunction in an elderly heart failure population. J Cardiac Fail 2014; 20: 09-104
35. Andersen MJ, Hwang SJ, Kane GC, Melevonsky V, Olson TP, Fetterly K, Borlaug BA. Enhanced pulmonary vasodilator reserve and abnormal right ventricular -pulmonary artery coupling in heart failure with preserved ejection fraction. Circ Heart Fail 2015; 8: 542-550
36. Mc Laughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-1619
37. Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J 2012; 163: 589-594
38. LeVarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J 2014; 44: 425-434
39. Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H. Reading pulmonary pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014; 190: 252-257
40. Dumitrescu D, Gerhardt F, Viethen T, Erdmann E, Rosenkranz S. 70 year-old patient with cardiac hypertrophy and severe pulmonary hypertension: Pre-or postcapillary? Dtsch Med Wochenschr 2011; 136: 2594-2598
41. Boerrigter BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, Systrom DM. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J 2014; 43: 1316-1325
42. De Oliveira RKF, Ferreira EVM, Ramos RP, Messina CMS, Kapins CEB, Silva CMC, Ota-Arakaki JS. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension. J Heart Lung Transplant 2014; 33: 157-162
43. Jacobs W, Konings TC, Heymans MW, Boonstra A, Bogaard HJ, van Rossum AC, Vonk-Noordegraaf A. Non-invasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension. Eur Respir J 2015; 46: 422-430
44. Thibodeau JT, Turer AT, Gualano SK, Ayers CR, Velez-Martinez M, Mishkin JD, Patel PC, Mammen PP, Markham DW, Levine BD, Drazner MH. Characterization of a novel symptom in patients with advanced heart failure: Bendopnea. JACC Heart Fail 2014; 2: 24-31
45. Olsson KM, Sommer L, Fuge J, Welte T, Hoeper MM. Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction. Respir Res 2015; 16: 34
46. Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014; 7: 116-122
47. Fujimoto N, Borlaug BA, Lewis GD, Hastings JL, Shafer KM, Bhella PS, Carrick-Renson G, Levine BD. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 2013; 127: 55-62
48. Van Empel VPM, Kaye DM. Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction. Int J Cardiol 2013; 168: 716-722
49. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550
50. Wachter R, Schmidt-Schweda S, Westermann D, Post H, Edelmann F, Kasner M, Lüers C, Steendijk P, Hasenfuss G, Tschöpe C, Pieske B. Blunted frequencydependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart J 2009; 30, 3027-3036
51. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure -abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953-1959
52. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009; 10: 165-193
53. D'Alto M, Romeo E, Argiento P, Pavelescu A, Mélot C, D'Andrea A, Correra A, Bossone E, Calabrò R, Russo MG, Naeije R. Echocardiographic prediction of pre-versus postcapillary pulmonary hypertension. J Am Soc Echocardiogr 2015; 28: 108-115
54. Arkles JS, Opotowsky AR, Ojeda J, Rogers F, Liu T, Prassana V, Marzec L, Palevsky HI, Ferrari VA, Forfia PR. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: 268-276
55. Rosenkranz S, Bondermann D, Buerke M, Felgendreher R, ten Freyhaus H, Grünig E, de Haan F, Hammerstingl C, Harreuter A, Hohenforst-Schmidt W, Kindermann I, Kindermann M, Kleber FX, Kuckeland M, Kübler WM, Mertens D, Mitrovic V, Opitz C, Schmeisser A, Schulz U, Speich R, Zeh W, Weil J. Pulmonary hypertension due to left heart disease: Updated recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011; 154: S34-S44
56. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; for the CHAMPION Trial Study Group. Wireless pulmonary artery hemodynamic monitoring in chronic heart failure: A randomized controlled trial. Lancet 2011; 377: 658-666
57. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, Henderson J, Cowart P, Stevenson LW. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 2014; 7: 935-944
58. Bursi F, Barbieri A, Grigioni F, Reggianini L, Zanasi V, Leuzzi C, Ricci C, Piovaccari G, Branzi A, Modena MG. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail 2010; 12: 382-388
59. Kusunose K, PopovićZB, Motoki H, Marwick TH. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging 2013; 6: 167-176
60. Lancellotti P, Magne J, Dulgheru R, Ancion A, Martinez C, Pierard LA. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. Am J Cardiol 2015; 115: 1554-1561
61. Gaemperli O, Moccetti M, Surder D, Biaggi P, Hurlimann D, Kretschmar O, Buehler I, Bettex D, Felix C, Luscher TF, Falk V, Grunenfelder J, Corti R. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012; 98: 126-132
62. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S; EVEREST II Investigators. Acute and 12 month results of catheter-based mitral valve leaflet repair: EVEREST II high risk study. J Am Coll Cardiol 2012; 59: 130-139
63. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013; 309: 1268-1277
64. Hoendermis ES, Liu LCY, Hummel YM, van Der Meer P, de Boer RA, van Veldhuisen DJ, Voors AA. Effects of sildenafil on invasive hemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: A randomized controlled trial. Eur Heart J 2015; 36: 2565-2573
65. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Semigran MJ. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007; 116: 136-144
66. Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary hypertension in heart failure with preserved ejection fraction: A target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011; 124: 164-174
67. Dumitrescu D, Seck C, Möhle L, Erdmann E, Rosenkranz S. Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension -results of compassionate care treatment. Int J Cardiol 2012; 154: 205-206
68. Wu X, Yang T, Zhou Q, Li S, Huang L. Additional use of a phophodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: A meta-analysis. Eur J Heart Fail 2014; 16: 444-453
69. Bonderman D, Ghio S, Felix SB, Ghofrani HA, Michelakis E, Mitrovic V, Oudiz RJ, Boateng F, Scalise AV, Roessig L, Semigran MJ, for the LEPHT Study Group. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: A phase IIb double-blind, randomized, placebo-controlled, doseranging hemodynamic study. Circulation 2013; 128: 502-511
70. Bonderman D, Pretsch I, Steringer-Mascherbauer R, Jansa P, Rosenkranz S, Tufaro C, Bojic A, Lam CSP, Frey R, Ocham Kilama M, Unger S, Rössig L, Lang IM. Acute hemodynamic effects of Riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): A randomized, double-blind, placebo-controlled, single-dose study. Chest 2014; 146: 1274-1285